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Ubiquitination modifies proteins in a variety of ways, the 
significance  of  which  we  only  partially  comprehend. 
Ubiquitin can be attached: as an individual moiety to a 
single or multiple lysine residues of substrate (mono- or 
multiple  monoubiquitination);  as  chains  of  ubiquitin 
moieties  that  are  interlinked  through  any  one  of  the 
seven lysine residues of ubiquitin (for example K48- or 
K63-linked chains); or as branched chains, to name but a 
few [1]. The cell interprets each of these modifications as 
a distinct signal. The first described role of ubiquitination 
as mediating protein degradation through targeting to 
the  proteasome  has  now  been  complemented  with 
numerous  other  functions  [2].  For  example,  the  signal 
encoded by K63-linked chains can mediate functions as 
diverse  as  receptor  endocytosis  [3,4],  activation  of 
protein kinases in the NF-κB pathway and the initiation 
of error-free DNA repair [2].
Signal transduction from transmembrane cell surface 
receptors to nuclear transcription factors is regulated at 
multiple  levels  by  protein  ubiquitination. The  covalent 
attachment of one, or often more, ubiquitin moieties has 
emerged as the principal mechanism for termination of 
signaling, by targeting the receptor for endocytosis and, 
ultimately, degradation in the lysosome [3]. This device 
controls a vast array of mammalian signaling receptors, 
such  as  receptor  tyrosine  kinases,  G-protein  coupled 
receptors  (GPCRs),  growth  hormone  receptors,  the 
major  histocompatibility  complex  I,  NOTCH,  various 
channels and transporters, and cytokine and interferon 
receptors  [3].  Receptors  that  are  internalized  after 
activation are directed first into the endosomes of the 
endocytic pathway, and then into multivesicular bodies 
(MVBs),  which  undergo  a  process  of  maturation  that 
ends with fusion with the lysosome and delivery of the 
contents for degradation. Ubiquitination of the receptor 
provides  the  crucial  signal  for  entering  this  pathway 
[3,5-7].
Subsequent  delivery  of  membrane  receptors  to  the 
lysosome  requires  accurate  recognition  of  the 
ubiquitinated cargo by endosomal adaptors and sorting 
proteins.  For  the  EGF  receptor,  for  example,  these  are 
EPS15, epsin and ESCRTs (endosomal sorting complexes 
required  for  transport),  which  contain  one  or  more 
ubiquitin-binding domains (UBDs) [8]. EPS15 and epsins 
act at the initial steps of internalization, serving to recruit 
the enzymes required for ubiquitination of downstream 
components  of  the  endocytic  pathway.  ESCRTs  act 
sequentially at various points of the degradative route, 
sorting  the  ubiquitinated  cargo  at  the  endosomal 
membrane for inclusion into the intraluminal vesicle of 
the  MVB.  ESCRT-0,  composed  of  the  two  interacting 
proteins  HRS  and  STAM,  is  the  first  in  this  process. 
Three  additional  complexes,  ESCRT-I,  ESCRTII  and 
ESCRT-III, are then involved in the generation of inward 
vesicle budding, which is required for MVB maturation 
(for  reviews  see  [5,9]).  The  ubiquitin-binding  ‘route 
controllers’  that  operate  in  this  way  to  ferry  the 
internalized  receptor  inexorably  towards  a  degradative 
fate in lysosomes are also inducibly ubiquitinated [10,11] 
(Figure 1).
The inducibility of the system illustrates the dynamic 
nature of ubiquitin-based endocytic regulation. Indeed, 
over the past 15 years, studies from different laboratories 
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down-regulation, a process that is essential for the spatial 
and temporal resolution of receptor signaling [3].
The central component of this regulatory pathway is 
the E3 ligase that attaches the ubiquitin molecules to the 
receptor, or to the ubiquitin-binding endocytic adaptors 
(Figure 1). A hierarchical set of three types of enzyme is 
required  for  substrate  ubiquitination:  ubiquitin-
activating (E1), ubiquitin-conjugating (E2) and ubiquitin-
protein  ligase  (E3)  enzymes.  In  mammals  two  E1-
activating  enzyme  transfer  ubiquitin  to  roughly  three 
dozen E2s, which function together with several hundred 
different E3 ubiquitin ligases to ubiquitinate thousands of 
substrates. In the endocytic pathway distinct E3 enzymes 
generally catalyze the ubiquitination of the cell-surface 
receptors  and  the  endosomal  sorting  proteins  [3]. 
Therefore the endocytic sorting of a given target generally 
involves more than one E3 ubiquitin protein ligase.
Here we focus on how signaling controls the activity of 
the E3 ligases that ubiquitinate receptors and endocytic 
adaptors.  Although  E3  ligases  have  largely  been 
considered to be constitutively active and regulated only 
at  the  level  of  target  binding,  it  has  recently  become 
evident that they are subject to regulation by either E3 or 
substrate phosphorylation, or by exploitation of adaptor 
proteins  that  facilitate  E3  activity. We  discuss  here  the 
various ways of regulating E3 ligases in the context of 
endocytosis.
Ligand-induced E3 ligases for receptor 
ubiquitination
Protein phosphorylation, which is well known to function 
in  recruitment  of  the  ubiquitination  machinery  to  the 
substrate  [12],  may  also  act  directly  to  regulate  the 
activity of distinct ubiquitin ligases.
The best-characterized circuitry involves the E3 ligase 
Cbl, which is responsible for the ubiquitination of several 
receptor  tyrosine  kinases  (RTKs)  [3].  The  mammalian 
Cbl protein family consists of the three homologs c-Cbl, 
Cbl-b,  and  Cbl-3,  all  of  which  associate  with  a  wide 
variety of signaling proteins [13]. Two highly conserved 
amino-terminal  domains  contribute  strongly  to  E3 
regulatory  function.  First,  the  amino-terminal  tyrosine 
kinase  binding  (TKB)  domain  of  Cbl  recognizes 
phosphotyrosine  residues  and  allows  Cbl  to  interact 
directly  with  activated  RTKs  at  the  plasma  membrane 
(Figure  2).  Second,  the  RING  finger  domain  recruits 
ubiquitin-loaded E2s, whose interaction with Cbl results 
in the ubiquitination and subsequent degradation of the 
associated  RTK.  In  the  case  of  the  epidermal  growth 
factor receptor (EGFR) and the hepatocyte growth factor 
receptor  MET,  the  molecular  mechanism  of  receptor 
ubiquitination  has  been  investigated  in  detail.  In  both 
cases, Cbl binds directly to phosphotyrosine (pY)-sites on 
the activated receptor through its TKB [14,15], as well as 
indirectly through its constitutive partner GRB2, which is 
recruited to receptors via other pY sites [7,16-18]. Both 
direct and indirect interactions of Cbl with the EGFR or 
MET  are  required  for  full  ubiquitination  of  these 
receptors  (Figure  2).  Once  bound,  the  ligase  is 
phosphorylated  and  consequently  activated  [19].  Two 
Figure 1. Receptor internalization and the role of ubiquitin. The 
example shown here is that of the EGF receptor. An activated EGFR 
is ubiquitinated at the plasma membrane and recruits the endocytic 
adaptor proteins EPS15 and EPSIN-1. These are ubiquitinated, in 
turn, and direct the internalized receptor to the endosomal pathway 
where it binds the sorting protein HRS. This is also ubiquitinated and 
directs progression of the ubiquitinated receptors towards lysosomal 
degradation through the ESCRT complexes. For simplicity, the EGF 
receptor is depicted as monoubiquitinated: in reality, it is both 
multimono- and polyubiquitinated. MVB, multivesicular body.
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Page 2 of 9structural studies have now shed light on the mechanism 
of  phosphorylation-induced  activation  of  c-Cbl  and 
Cbl-b  [20,21].  In  the  absence  of  substrate  binding,  the 
TKB  and  RING  domains  form  a  compact  structure  that 
masks  the  E2  binding  site.  Binding  of  the  TKB  to  the 
substrate  induces  a  first  rotation  of  the  linker  region, 
allowing phosphorylation of tyrosine 371 (363 in Cbl-b). 
This phosphorylation event induces a complete rotation 
of the linker region that unmasks the RING E2 binding 
surface and activates the ligase [20,21].
Another  class  of  E3  ligases,  the  HECT  NEDD4  family 
[22], whose regulation has been extensively studied, also 
regulates endocytosis and sorting of numerous signaling 
receptors  [3,5-7].  These  enzymes  present  a  conserved 
modular  organization  with  an  amino-terminal  C2 
domain  that  is  crucial  for  membrane  localization, 
between  two  and  four  WW  domains  capable  of 
recognizing substrates and adaptor proteins through PY 
motifs,  and  a  carboxy-terminal  catalytic  HECT  domain. 
In contrast to RING-based ligases in which the RING is 
an  allosteric  activator  of  the  E2,  HECT-containing  E3s 
have intrinsic catalytic activity and directly ubiquitinate 
their targets. In humans, there are nine members of this 
family:  NEDD4  (also  known  as  NEDD4-1),  NEDD4L 
(also  known  as  NEDD4-2),  ITCH  (also  known  as  AIP4), 
WWP1,  WWP2,  SMURF1,  SMURF2,  NEDL1  (also 
known as HECW1) and NEDL2 (also known as HECW2). 
Rsp5  is  the  unique,  essential  member  of  the  NEDD4 
family in Saccharomyces cerevisiae. In normal conditions 
most of them appear to be in an inactive state because of 
an  intramolecular  inhibitory  interaction  between  the 
carboxy-terminal  HECT  and  the  amino-terminal  C2 
domain  (in  the  case  of  SMURF2,  NEDD4  and  WWP2 
[23])  or  the  WW  domains  (in  the  case  of  ITCH  [24]). 
Activation of this class of enzyme can occur in various 
ways that are briefly described below.
ITCH  is  the  E3  ligase  for  the  chemokine  receptor 
CXCR4 [25]. The ubiquitin moiety on CXCR4 serves as a 
signal  on  endosomes  for  entry  into  the  degradative 
pathway and long-term attenuation or downregulation of 
signaling  [25].  ITCH  can  interact  directly  with  CXCR4 
through  a  non-canonical  WW  domain-mediated 
interaction involving serine residues within the carboxy-
terminal  tail  of  CXCR4.  These  serine  residues  are 
phosphorylated upon agonist activation, and are critical 
for mediating agonist-promoted binding of ITCH and the 
subsequent  ubiquitination  and  degradation  of  CXCR4 
[26] (Figure 3a). Also in this case, the ligase appears to be 
regulated  by  phosphorylation.  ITCH  phosphorylation  is 
activated  by  JNK1  [24],  and  is  thought  to  lead  to 
Figure 2. EGFR ubiquitination by Cbl. Upon EGF-dependent receptor activation, the GRB2-Cbl complex binds to the receptor through 
interactions of: i) the SH2 domain of GRB2 with pY1045 of EGFR, and ii) the TKB domain of Cbl (either c-Cbl or Cbl-b) with pY1068 or pY1086. 
This substrate interaction may either stabilize or select for a partially open Cbl conformation (see bottom panel and main text). EGFR-bound Cbl 
becomes phosphorylated on a critical tyrosine, leading to full rotation of the linker region. This, in turn, exposes the RING domain for ubiquitin-
charged E2 binding, resulting in the allosteric activation of the E2 by Cbl and ubiquitination of the EGFR. Note that, to simplify the picture, Cbl 
bound to one receptor molecule is depicted to ubiquitinate the other molecule of the dimer. No available data suggest that this is indeed the case. 
For simplicity, the EGF receptor is depicted as monoubiquitinated: in reality, it is both multimono- and polyubiquitinated.
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Page 3 of 9conformational  changes  that  disrupt  the  inhibitory 
intramolecular  interactions  between  its  WW  and  the 
HECT domains.
In  the  case  of  SMURF2,  autoinhibition  of  the  HECT 
domain  by  the  C2  domain  helps  in  maintaining  the 
steady-state levels of this E3 ligase and can be relieved by 
adaptor-mediated substrate targeting [23]. SMURF1 and 
SMURF2  bind  to  TGF-β  family  receptors  through  the 
inhibitory  Smad  proteins,  SMAD6  and  SMAD7,  to 
induce their ubiquitin-dependent degradation. Wiesner 
et al. [23] demonstrated that intramolecular interactions 
between  the  C2  and  HECT  inhibit  SMURF2  catalytic 
activity  interfering  with  ubiquitin  thioester  formation. 
This in cis autoinhibition can be relieved by binding of 
the  amino-terminal  domain  (NTD)  of  the  adaptor 
protein SMAD7 to the E3 HECT domain (Figure 3b). The 
SMAD7  NTD  further  enhances  the  catalytic  activity  of 
the  SMURF2  ligase  by  recruiting  the  E2  UbcH7  to  the 
HECT  domain  [27].  By  releasing  C2-mediated 
autoinhibition,  stimulating  E2  binding,  and  recruiting 
SMURF  targets,  SMAD7  functions  at  multiple  levels  to 
control  E3  activity  and  ensure  specificity  in  SMURF-
catalyzed ubiquitination.
Recently, a role for a UBD present on the N-lobe of the 
HECT  domain  of  NEDD4  and  Rsp5  has  been  identified 
[28,29].  The  ability  of  the  HECT  domain  to  bind  non-
covalently to the distal ubiquitin at the growing end of 
the polyubiquitin chain on the substrate allows enzyme 
Figure 3. Activation of E3 ubiquitin ligases through recruitment to activated receptors. (a) Ubiquitination of CXCR4 by ITCH. ITCH activity 
is inhibited as a result of the intramolecular interaction between the WW domain and the carboxy-terminal catalytic HECT domain. Upon 
agonist-mediated activation, CXCR4 becomes phosphorylated at Ser324 and Ser325 by an unknown kinase. This leads to the recruitment of 
the ITCH, through its WW domain, and consequent release of the inhibitory intramolecular interaction, allowing ubiquitination of the receptor. 
(b) Ubiquitination of the TGF-β receptor by the SMURF2-SMAD7 complex. SMURF2 activity is inhibited as a result of the intramolecular interaction 
between the amino-terminal C2 and the carboxy-terminal catalytic HECT domain. The interaction with SMAD7 NTD displaces the C2 domain 
of SMURF2 from the HECT domain and activates the ligase. The activated SMURF2-SMAD7 complex associates with activated TGF-β receptor 
complexes at the membrane via the displaced C2 domain, causing receptor ubiquitination.
CXCR4
S
S S
S
ITCH
S
S
U
P
P
WW
P
P
P
A
P
To endocytosis
and degradation
TGFβ-R TGFβ-R
C2
HECT
HECT
WW
C2
HECT
WW
C2
HECT
SMURF2
ITCH
B
HECT WW
C2
SMAD7
NTD
MH2
NTD
MH2
U
To endocytosis
(a)
(b)
CXCR4
S
S S
S
ITCH
S
S
U
P
P
WW
P
P
P
A
P
To endocytosis
and degradation
TGFβ-R TGFβ-R
C2
HECT
HECT
WW
C2
HECT
WW
C2
HECT
SMURF2
ITCH
B
HECT WW
C2
SMAD7
NTD
MH2
NTD
MH2
U
To endocytosis
(a)
(b)
(a)
(b)
Polo BMC Biology 2012, 10:25
http://www.biomedcentral.com/1741-7007/10/25
Page 4 of 9processivity [28]. It is tempting to attribute an inhibitory 
role  of  the  C2  binding  for  this  critical  feature  of  these 
enzymes.  Accessibility  of  the  UBD  may  be  restored  in 
response to upstream signaling events capable of inducing 
phosphorylation and/or ubiquitination of critical sites in 
the  C2  or  in  the  HECT  domain,  leading  to  full  ligase 
activation. While this hypothesis needs to be experimentally 
verified,  we  notice  that  ubiquitination  of  NEDD4  is  a 
critical  event  for  the  coupled  monoubiquitination  of 
EPS15 ([30] and below).
In some cases, such as for the epithelial Na+ channel 
(ENaC),  receptor:ligase  interaction  –  and  consequent 
receptor  ubiquitination  –  is  the  default  pathway,  with 
phosphorylation  negatively  regulating  ligase  activity. 
NEDD4-2  binds  constitutively  to  ENaC  PPxY-containing 
motifs  and  catalyzes  its  ubiquitination,  internalization 
and lysosomal targeting. This prevents Na+ overload in 
epithelial cells and is necessary for the maintenance of 
salt  and  fluid  balance  in  the  body.  To  increase  ENaC 
abundance  at  the  surface  and  enhance  epithelial  Na+ 
absorption,  NEDD4-2  is  phosphorylated  by  various 
kinases,  including  protein  kinase  A  (PKA),  serum-  and 
glucocorticoid-inducible  kinase  (SGK),  and  IκB  kinase 
(IKK)β  (Figure  4a).  Phosphorylation  induces  binding  of 
14-3-3 proteins, which prevents NEDD4-2 from binding 
to ENaC [31-33].
Regulation of receptor ubiquitination by adaptor 
proteins
Finally, specific binding proteins can regulate the process 
of  ubiquitination  by  acting  as  adaptors  to  recruit  E3 
proteins to receptors that lack a direct binding motif for 
the ligase (reviewed in [34]). The best evidence for this 
mechanism  so  far  comes  from  membrane  transport 
directed by the yeast HECT E3 ligase Rsp5, which is the 
unique  homolog  of  the  mammalian  NEDD4  family 
proteins. While in humans there are nine members of the 
NEDD4  family,  yeast  Rsp5  is  sufficient  on  its  own  to 
control most membrane traffic ubiquitination events at 
the plasma membrane and at other biomembranes [35]. 
Cooperation  with  adaptors  such  as  Bul1/Bul2,  Bsd2/
Tre1/Tre2, or Ear1/Ssh4 enables Rsp5 to cope with this 
large number of substrates [35], and the discovery of the 
yeast family of ARR-related proteins (ARTs), which direct 
Rsp5 activity to various plasma membrane receptors [36-
38],  shows  that  the  adaptor  mechanism  is  even  more 
extensive  than  previously  thought  (Figure  4b).  Does 
receptor signaling regulate these HECT adaptor proteins? 
Figure 4. Regulation of channels and transporters by ubiquitination. (a) ENaC ubiquitination by NEDD4-2. NEDD4-2 binds to PY motifs 
on the epithelial Na+ channel ENaC and catalyzes its ubiquitination. This induces ENaC endocytosis and lysosomal targeting, resulting in fewer 
channels at the cell surface. To increase Na+ transport, NEDD4-2 is phosphorylated by kinases, including PKA, SGK, and IKKβ, in turn activated by 
various signaling pathways. Phosphorylation of NEDD4-2 induces binding of 14-3-3 dimers (not shown), which prevents NEDD4-2 from binding 
to ENaC. As a result, endocytosis of ENaC is inhibited, and increased ENaC presence at the surface enhances epithelial Na+ absorption. (b) Rsp5 
ubiquitinates permeases and transporters. In yeast, arrestin-related endocytic adaptors (ARTs) and the E3 ubiquitin ligase Rsp5 are recruited to the 
plasma membrane in response to environmental stimuli that trigger the endocytosis of proteins such as permeases and transporters (for example, 
the arginine transporter Can1). Through their PY motifs, ARTs bind to the WW domain of Rsp5 and mediate ubiquitination of cargo. ARTs are also 
ubiquitinated by Rsp5, an event required for endocytosis.
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Page 5 of 9Two recent papers provide evidence that it does [39,40]. 
MacGurn  et  al.  [40]  demonstrated  that  signaling  from 
TORC1,  which  is  a  central  regulator  of  cell  growth  in 
response  to  amino  acid  availability,  regulates  Rsp5 
targeting and endocytosis of nutrient transporters at the 
plasma  membrane.  The  effector  mechanism  that 
regulates  endocytosis  involves  a  TORC1-Npr1  negative 
kinase signaling cascade that tunes the phosphoinhibition 
of  the  ubiquitin  ligase  adaptor  Art1  [40].  Leon  and 
colleagues  [39]  identified  the  α-arrestin  Rod1/Art4   
as  a  direct  target  of  the  glucose  signaling  pathway. 
Glucose  promotes  Rod1/Art4  dephosphorylation  and   
its  subsequent  release  from  a  phospho-dependent 
interaction  with  14-3-3  proteins.  This  allows  Rsp5-
mediated  Rod1  ubiquitination,  a  prerequisite  for 
transporter endocytosis [39]. It is conceivable that other 
signaling pathways may similarly regulate the activity of 
other ART family proteins.
Does this mechanism also operate in mammals? And if 
yes,  how? These  important  gaps  in  our  understanding 
need  to  be  filled.  Of  note,  arrestin  domain  containing 
protein 3 (ARRDC3) was recently shown to interact with 
NEDD4 and to be an essential adaptor for β2-adrenergic 
receptor (β2AR) ubiquitination [41].
Ligand-induced E3 ligases for adaptor 
ubiquitination
The adaptors we have just discussed function to recruit 
E3 ligases to receptors. We now return to the endocytic 
adaptors that are recruited to the ubiquitinated receptors 
and direct their subsequent endocytosis. As with direct 
receptor ubiquitination, the ubiquitination of endocytic 
adaptors plays a critical role in endocytosis. The arrestin 
(ARR) family of proteins is able to direct internalization 
of  GPCR  cargo.  Signaling  from  activated  GPCRs  is 
terminated  when  GPCRs  are  phosphorylated  by  GPCR 
kinases  (GRKs),  leading  to  the  recruitment  of  ARR, 
which binds to AP-2 and clathrin, structural components 
of the vesicles formed at the plasma membrane causing 
the whole complex to be internalized. Agonist-stimulated 
ubiquitination of ARR mediated by the E3 ligase murine 
double minute (MDM2), an important negative regulator 
of p53, is critical for rapid receptor internalization [42]. 
MDM2-ARR binding is constitutive and does not persist 
after receptor activation, suggesting that ubiquitin modi-
fication  might  cause  a  conformational  change  on  ARR 
required to promote internalization. GPCRs themselves can 
also be ubiquitinated, most probably by NEDD4, an event 
required for cargo degradation but not internalization [43]. 
Thus by analogy with the ‘phosphorylation code’ on the 
receptor  carboxy  tail,  ubiquitin  modifications  on  both 
adaptors and receptors result in a ‘ubiquitination code’ 
that fine-tunes signal strength, localization, and cellular 
functions of GPCR (Figure 5a).
ARR is not the sole example of an endocytic adaptor 
subjected to ubiquitin modification. Several components of 
the downstream endocytic machinery are monoubiquitinated 
upon RTK activation [10,11,44,45]. In most cases, these 
adaptors are ubiquitin receptors that are ubiquitinated by 
the E3 ligase NEDD4. The presence of a UBD is required 
for  monoubiquitination  of  the  UBD-harboring  adaptor, 
in a process termed coupled monoubiquitination whose 
molecular  workings  have  been  elucidated  using  the 
endocytic proteins EPS15 and EPSIN-1 as models [30,46] 
(Figure  5b).  By  contrast,  the  mechanism  by  which 
NEDD4  recruitment  is  induced  by  the  activated  EGFR 
remains to be clarified.
What  is  the  role  of  adaptor  ubiquitination? 
Monoubiquitination  might  permit  the  formation  of 
several tiers of ubiquitination-dependent interactions in 
the endosome, by allowing binding of ubiquitinated cargo 
(through UBDs) and recruiting another layer of ubiquitin 
receptors through the monoubiquitin signal. The result 
would  be  signal  amplification  and  progression  of 
ubiquitinated cargoes along the endocytic pathway.
Monoubiquitination  of  ubiquitin  receptors  may  also 
result  in  an  intra-molecular  interaction  between  their 
UBDs  and  monoubiquitinated  residues,  with  resulting 
dissociation from the ubiquitinated cargo [47,48]. These 
two  possibilities  are  not  mutually  exclusive  and  both 
mechanisms  may  be  involved  in  the  regulation  of 
endocytic processes, possibly by acting at distinct steps 
and/or regulating different endocytic adaptors.
Is the ubiquitination cascade like 
the phosphorylation cascade?
It is important to realize that the power of ubiquitin stems 
from its capacity to act as a protein-protein interaction 
module that targets substrates to a plethora of downstream 
effectors. In order to realize this network, complex molecular 
machines generate and recognize signal diversity based 
on ubiquitin-binding modules. The network is fine-tuned 
by  ubiquitinating  (E3  ligases)  and  deubiquitinating 
enzymes  (DUBs)  that  balance  the  absolute  levels  of 
protein  ubiquitination,  as  well  as  the  abundance  and 
localization  of  adaptors  that  contain  docking  sites  for 
specific ubiquitinated proteins (UBDs) [49].
One  such  network  pivots  around  EGFR.  EGF 
stimulation  promotes  ubiquitination  of  EGFR  and  of 
EGFR  endocytic  adapters,  providing  a  striking  example 
of concerted regulation of signaling, ultimately regulating 
the  route  of  EGFR  internalization  [50,51].  Our  own 
approach  to  understanding  the  complex  interplay 
between EGFR-induced signaling circuitries has been the 
recent  elucidation  of  the  EGF-induced  ‘ubiproteome’ 
[52].  This  work  has  uncovered  an  extensive  ubiquitin-
based signaling network that impinges on a wide array of 
signaling  circuitries  and  various  aspects  of  cellular 
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Page 6 of 9physiology  including  DNA  repair,  nuclear  transport, 
mRNA  processing,  metabolic  pathways,  and  ribosome 
biogenesis.  Interestingly,  many  ubiquitin  machinery 
enzymes were detected in the EGF-induced ubiproteome. 
Regardless  of  the  initial  triggering  mechanism  (which 
necessarily involves the kinase activity of the EGFR), the 
ubiquitin signal seems to be rapidly transmitted to, and 
amplified through, the ubiquitin machinery. Just as in the 
phosphorylation cascade, in which critical enzymes such 
as  kinases  and  phosphatases  are  often  activated  by 
phosphorylation,  ubiquitinating  enzymes  appear  to  be 
regulated by ubiquitination. Moreover, a comparison of 
the  EGF-induced  ubi-  and  pY-proteomes  revealed  a 
significant overlap and identified many highly connected 
‘hub’  proteins  that  are  both  phosphorylated  and 
ubiquitinated  [52].  These  data  suggest  that  two 
complementary and interlinked enzymatic cascades drive 
the flow of information from receptors to downstream 
signaling  molecules:  kinases/phosphatases  and  E3 
ligases/DUBs.  In  essence,  these  two  post-translational-
modification-based  networks  can  be  conceptualized  as 
two  overlapping,  diffusely  interconnected,  matrices 
Figure 5. Ubiquitination of adaptors. (a) Agonist induces rapid ubiquitination of GPCR-recruited ARR by MDM2, a process required for receptor 
internalization. Once internalized, GPCRs can be dephosphorylated and rapidly recycled to the plasma membrane through a mechanism that 
involves the sorting proteins EBP50 and NSF. (b) Activated EGFR is ubiquitinated at the plasma membrane by Cbl and recruits the UBD-containing 
endocytic adaptors EPS15 and EPSIN-1 at the plasma membrane, and subsequently HRS at the endosomal membrane. These adaptors, in turn, are 
ubiquitinated by NEDD4 through a process known as coupled monoubiquitination. This directs progression of the ubiquitinated receptors toward 
lysosomal degradation through the ESCRT complexes. A similar mechanism can be envisioned for other RTKs.
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Page 7 of 9through  which  external  signals  are  transduced  and 
interpreted  by  the  cell.  To  understand  how  this  is 
achieved,  a  multidisciplinary  approach  is  required.  No 
single ‘omics’ analysis can fully unravel the complexities 
of the system. Complete understanding will be achieved 
only  by  integrating  information  from  high-resolution 
molecular  investigations,  ‘omics’  approaches  and  ‘top-
down’ systems-based modeling.
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